On-Demand Cardiology Pharmacology CME

Outline an evidence-based approach to primary prevention of ASCVD events with a focus on LDL-C.

A focused review of optimizing LDL-C for secondary prevention.

Discuss established and emerging therapies to reduce LDL-C.

Review the effects of PCSK9 inhibitors on coronary plaque.

Identify optimal LDL-C levels for patients with very high risk ASCVD.

Understand the role of triglycerides in residual risk beyond LDL-C.

Review the potential role of fish oils to reduce risk of CV events.

Novel approaches to TG lowering

Update on Lipoprotein (a)

What about HDL-C – should we even bother?

Review epidemiology and burden of heart failure.

Provide a pragmatic, patient-centered review of contemporary HF management.

Discuss recent clinical trials of novel therapies and outline the role of “quadruple therapy” for patients with HF reduced ejection fraction.

Review evidence-based therapies for patients with HF preserved ejection fraction.

Review epidemiology and burden of heart failure (with preserved EF).

Discuss the recommended approach for diagnosing HFpEF and the critical importance of phenotyping.

Review evidence-based therapies for patients with HF preserved ejection fraction with a particular focus on the obese-HFpEF profile.

Review the pathobiology and epidemiology of cardiovascular- kidney-metabolic syndrome.

Comprehensive review of clinical trials data for cardio-kidney- metabolic therapies (from the CV perspective).

ASCVD + DM

HF (across spectrum of EF; with or without DM)

CKD (across spectrum of CKD; with or without DM)

Obesity + ASCVDItem description

Review the pathophysiology and management of acute coronary syndromes

Understand the role of invasive and non-invasive testing in the management of chest pain

Develop an approach to statin associated muscle symptoms

Diagnose and manage atrial fibrillation including the role of early ablation

Review guidelines for the management of aortic stenosis and mitral regurgitation

Apply the latest hypertension guidelines to achieve optimal BP in patients across CV risk spectrum

Understand the role of pre-operative cardiac testing for patients undergoing non-cardiac surgery

Diagnose and management patients with amyloid heart disease

Discussion of 4 cases

Discussion of 5 cases